Patents for C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897) |
---|
11/24/2005 | US20050261259 Phytosterol and/or phytostanol derivatives |
11/23/2005 | CN1699397A Process for preparing notoginseng triol saponin and use thereof |
11/23/2005 | CN1699396A Process for preparing notoginseng diol saponin |
11/23/2005 | CN1228343C Substance having steroid-like structure, process for production thereof and antitumor agents containing same |
11/22/2005 | US6967195 2-substituted ring A aromatic sterol derivatives having a comparatively short 17-position hydrocarbyl side chain terminates in an carboxaldehyde or hydroxy group; antiproliferative and antiangiogenic agent |
11/17/2005 | US20050256093 Branched polyamine steroid derivatives |
11/16/2005 | EP1248768B1 Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same |
11/16/2005 | CN1696144A Technique for preparing malonyl ginsenoside, and application of medication in treating diabetes |
11/16/2005 | CN1227259C Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism |
11/16/2005 | CN1227212C Method for preparing fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
11/10/2005 | US20050250953 Phytosterols, squalene and Vitamin E are recovered from phytonutrients concentrate derived from crude palm oil via esterification, transesterification, vacuum distillation, saponification, crystallization and organic solvent paretitioning |
11/09/2005 | CN1226303C High yield separating method for ginseng saponin Rb1 |
11/08/2005 | US6963010 Hydrophobic polyamine analogs and methods for their use |
11/08/2005 | US6962909 Treatment of neovascularization disorders with squalimine |
11/01/2005 | CA2459351C Methods for treating deodorizer distillate |
10/27/2005 | WO2005079164A3 5α-REDUCTASE INHIBITORS |
10/26/2005 | EP1063999B1 Epiallopregnanolone in the treatment of cns disorders |
10/19/2005 | EP1585724A2 Method of reducing toxicity of retinoids |
10/19/2005 | EP1585723A2 Modified retinoid compounds and their uses |
10/19/2005 | CN1684971A Novel structures and compositions comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease, its underlying co |
10/19/2005 | CN1683387A Method for extracting momordica glycoside from momordica grosvenori |
10/18/2005 | US6956125 Partial glycerides are subjected to a first transesterification step under mild conditions and, after working up and the removal of impurities, the sterol esters are subjected to a second transesterification |
10/13/2005 | WO2005095435A1 Method for producing pregnane derivative |
10/13/2005 | WO2005094838A1 Drugs, foods and drinks for ameliorating hyperglycemia |
10/13/2005 | US20050227954 Hypoglycemic agent |
10/12/2005 | CN1679959A Liver targeted auxiliary material containing D-glactose and sterol and its use |
10/06/2005 | WO2005058934A3 Glycosylated steroid derivatives with anti-migratory activity |
10/06/2005 | US20050222098 Regulation of meiosis |
10/05/2005 | CN1221564C Steride, its systhesis method and use |
10/04/2005 | US6951877 Materials and methods for treating hypercholesterolemia |
09/29/2005 | WO2005090379A1 Compounds and sensor for detecion of polycyclic aromatic hydrocarbons |
09/28/2005 | CN1220697C Pyloric spirobacterium inhibitor |
09/27/2005 | US6949533 use in treating asthma, allergy, arthritis and thrombosis |
09/22/2005 | US20050209174 Especially conjugating derivatives of paclitaxel, cholesterol, camptothecin, and rhodamine123 to transferrins, side effect reduction |
09/21/2005 | CN1671858A Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
09/21/2005 | CN1219790C C60 glucocorticoid and it use |
09/14/2005 | EP1572715A1 Steroid compounds with anti-tumor activity |
09/14/2005 | CN1668631A Fractionation of phytosterol esters in oil |
09/09/2005 | WO2005082925A2 Novel steroid agonist for fxr |
09/07/2005 | EP1404901B1 Method for preparing organic, in particular lithocholic acid, nanotubes and uses thereof |
09/01/2005 | WO2005079164A2 5α-REDUCTASE INHIBITORS |
08/31/2005 | EP1568706A1 Novel steroid agonist for FXR |
08/31/2005 | EP1392714B1 Steroids as agonists for fxr |
08/31/2005 | CN1662549A Glucocorticoid receptor ligands for the treatment of metabolic disorders |
08/31/2005 | CN1660885A Sulfonated sterol, preparing method and application |
08/31/2005 | CN1216861C Crystals of vitamin D derivatives and process for the preparation thereof |
08/31/2005 | CN1216607C Neurotoxicity inhibiting compsns. contg. ginsenoside Rg3 or ginsenoside Rh2 transferring glu |
08/25/2005 | US20050187202 Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols |
08/25/2005 | US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
08/24/2005 | EP1504019B1 Platinum complexes having antitumor activity |
08/24/2005 | EP1226156B1 Process for producing phytosterols by saponification in an alcohol/water solvent |
08/24/2005 | CN1659174A Method of storing hydrogen, hydrogen inclusion compound and process for producing the same |
08/24/2005 | CN1216065C Production method of oryzanol extracted by solvent extraction process |
08/23/2005 | US6933383 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone. |
08/18/2005 | WO2005023830A3 Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases |
08/18/2005 | CA2555453A1 Cross-coupling process for production of aromatic compounds from aliphatic organic compounds and aromatic organometallic reagents |
08/17/2005 | CN1655806A Treatment of diseases involving defective gap junctional communication |
08/17/2005 | CN1215080C Substd. sapogenins and their use |
08/11/2005 | US20050176976 GABA a modulating neurosteroids |
08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
08/11/2005 | US20050175976 Meiosis activating sterol augments implantation rate |
08/10/2005 | CN1653082A Platinum complexes having antitumor activity |
08/10/2005 | CN1652794A Neuroprotective spirostenol pharmaceutical compositions |
08/10/2005 | CN1651452A Panaxcoside secondary glucoside fatty acid ester compound, its preparation method and medicinal composition using said compound as active ingredient |
08/10/2005 | CN1651451A 20(SO)ortho ginseng diol derivative, medicinal composition containing them and its application |
08/04/2005 | WO2005070949A1 Di-steroidal prodrugs of estradiol |
08/04/2005 | WO2005070435A1 Agent for improving dynamic eyesight |
08/04/2005 | US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity |
08/04/2005 | CA2553815A1 Di-steroidal prodrugs of estradiol |
08/03/2005 | EP1559720A1 Method of separating ergosterol |
08/03/2005 | EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
08/03/2005 | CN1649653A Methods for treating deodorizer distillate |
08/02/2005 | US6924275 Aminophenol derivatives and their use in cosmetics |
07/27/2005 | EP1556406A1 Derivatives comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease |
07/27/2005 | CN1646556A Blanched polyamine steroid derivatives |
07/21/2005 | US20050159399 Reacting an estradiol with a linking goup slected from a carbonate, a polyoxyethylene glycol and succinic anhydride, an aliphatic diacid, a peptide linkage having 2-15 amia tert-butoxycarbonyl protected cysteic acidno acids |
07/20/2005 | CN1211087C Competitive progesterone antagnoists for regulating female fertility as required |
07/13/2005 | EP1551860A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
07/13/2005 | CN1639184A Process of extracting and purifying phytosterols and phytostanols from tall oil pitch |
07/13/2005 | CN1637017A Crystals of a vitamin D derivative and a method for the preparation thereof |
07/12/2005 | US6916835 Nitrate esters and their use for neurological conditions |
07/06/2005 | EP1550433A1 Use of ecdysteroids for teh preparation of cosmetic or dermatologic compositions for avoiding the hair loss |
07/06/2005 | CN1634970A Process for preparing notoginsen triterpenes |
07/06/2005 | CN1634969A Cholestrin derivative as nucleoside analog |
07/06/2005 | CN1634968A Process for extracting purified beta-sterol from concentrated residue of paclitaxel extraction |
06/30/2005 | WO2005058934A2 Glycosylated steroid derivatives with anti-migratory activity |
06/30/2005 | US20050143365 Structural modification of 19-norprogesterone I: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
06/30/2005 | US20050143364 21-Substituted progesterone derivatives as new antiprogestational agents |
06/30/2005 | CA2549074A1 Glycosylated steroid derivatives with anti-migratory activity |
06/29/2005 | EP1548025A2 Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
06/23/2005 | US20050137175 Composition with ecdysteroid with water or milk for lotions for skin and applying to prevent hair loss |
06/22/2005 | CN1630528A Brain cell or nerve cell protecting agents comprising ginseng |
06/22/2005 | CN1629179A Ganoderma lucidum sterol extract and its preparation process and application |
06/14/2005 | US6905687 Fusion proteins; immunogens; solid phase synthesis; kits |
06/09/2005 | WO2005005453A3 Novel compounds and compositions comprising sterols and/or stanols and cholesterol biosynthesis inhibitors and use thereof in treating or preventing a variety of diseases and conditions. |
06/08/2005 | EP1537068A1 Materials and methods for treating hypercholesterolemia |
06/08/2005 | CN1204892C Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
06/02/2005 | WO2005049037A1 Process for preparing phytosterol dispersions for application in beverages |
06/01/2005 | EP1534298A2 Novel anticholesterol compositions and method for using same |
06/01/2005 | CN1203861C Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside Rb1 |